Design and Implementation of an Opt-Out, End-to-End, Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine In Southeastern Ontario, increased patient distance from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback